The clinical trial to position immunomodulator Sepsivac as a drug has begun at PGIMER Chandigarh, said Dr. Ram Vishwakarma, coordinator of the trial program for the use of Sepsivac in COVID-19 treatment.It will be given to them as a vaccine," said Dr ...
The Council of Scientific and Industrial Research (CSIR) and Indian Institute of Integrative Medicine (IIIM) are working together for testing COVID-19 samples. ...